Stock comparison

BSXvsMDT

Boston Scientific CorpvsMedtronic PLC. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BSX

Boston Scientific Corp

$64.87

-29.93%

Health Care$91.9BNYSE

MDT

Medtronic PLC

$83.79

-14.76%

Health Care$111.2BNYSE

60-day price, rebased to 100

BSX -30.83% · MDT -18.42%

Round-by-round

BSX 3·MDT 3

EdgeMDT

Valuation upside

-27.90% vs -26.00% to DCF fair value

EdgeBSX

Balance-sheet strength

Altman Z 3.90 vs 2.76

EdgeBSX

Fundamental quality

Piotroski 9.00 vs 3.00 (of 9)

EdgeBSX

Growth + margins

Rule-of-40 36.80 vs 15.50

EdgeMDT

60-day momentum

-30.83% vs -18.42% price return

EdgeMDT

Market-cap liquidity

$91.9B vs $111.2B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBSXorMDT

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.